INTRODUCTION 52 53
Influenza is an acute respiratory disease responsible for seasonal epidemics and sporadic 54 pandemic outbreaks, leading to significant mortalities in humans [1, 2] . The most severe 55 complication is acute pneumonia, which develops rapidly and may result in respiratory failure 56 and death. Influenza A virus (IAV) pathogenesis is a multifactorial process, involving 57 increased viral replication competence and a harmful inflammatory response. Lipid mediators 58 lipoxins, protectins and resolvins that play a key and active role in the resolution of acute 59 inflammation have received a particular interest in infectious disease lately [3, 4] . Viruses were produced and titrated as previously described [12] . Purified virus particles were 118 obtained from MDCK cells supernatants as done previsouly [13] . Immunogold labeling of 119 ANXA1 and HA was performed on gradient-purified virus particles as previously described 120 determined by plaque assay, as previously described [12] . 175
176

Statistical analysis 177
The Mann-Whitney test was used for statistical analysis, regarding viral replication and 178 cytokine production. Kaplan-Meir method was used to calculate the survival fractions in in 179 vivo experiments. Two survival curves were compared by the log-rank test (Mantel-Cox test). 180
Results were considered statistically significant at p < 0.05 (*). together with an increase virus replication might be responsible for a subsequent harmfull 315 inflammation of the lungs. Indeed, excessive inflammation is a well-known contributor of 316 lung damage during severe influenza, a process that limits respiratory capacity and may 317 account for IAV pathogenesis in humans [1, 22] . Consistently, along with increased viral 318 replication, FPR2 exacerbated lung inflammation during IAV infection, in mice. To our 319 knowledge, the role of FPR2 in the inflammatory process of virus infections has not been 320 previously described. Increase inflammation mediated by FPR2 might also be the 321 consequence of a direct activation of the ERK pathway, a known signaling mediator of 322 inflammation [23] . FPR2 controls platelet/neutrophil aggregates leading to the rapid 323 generation of circulating LXA4 that subsequently further activates FPR2 [24] . Thus, the 324 involvement of a dysregulated platelet activation, known to promote acute lung injury during 325 influenza cannot also be ruled out in the deleterious role of FPR2 [25, 26] . 326
Altogether our results show that FPR2 is an important receptor involved in IAV pathogenesis, 327 acting both at the level of IAV replication and inflammation. Our results also suggest that 328 inhibitors of FPR2 should be explored as a novel strategy for the treatment of IAV infections. 329 
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